share_log

Needham Reiterates Hold on Lexicon Pharmaceuticalsto Hold

Benzinga ·  Dec 23 19:56

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) from Hold to Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment